维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="BOOSER D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer显示文摘	BOOSER D ESTEVA F RIVERA E	2002	Cancer Chemother Pharmacol2002，50，1：	1
2	Phase II study ofliposomalannamycin in the treatment of doxorubicin-resistant breast cancer显示文摘	Booser D J Esteva F J Rivera E	2002	Cancer Chemotherapy and Pharmacology2002，50，1：	1
3	Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer显示文摘	IWAMOTO T BIANCHINI G BOOSER D	2011	Journal of the National Cancer Institute2011，103，3：	1
4	Phase Ⅱ study of weekly docetaxel and trastuzumab for patients with HER2- overexpressing metastatic breast cancer显示文摘	Esteva FJ Vaiero V Booser D	2002	J Clin Oncol2002，20，7：	1
5	Phase II study of weekly docetaxel and trastuzumab for patients with HER-2- overexpressing metastatic breast cancer 显示文摘	Esteva FJ Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
6	Phase I1 study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer 显示文摘	Esteva FJ Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
7	Phase Ⅱ trial of weekly docetaxel and trastuzumab for patients with HER2- overpressing metastatic breast cancer 显示文摘	Esteva F J Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
8	Estrogen receptor(ER)mRNA and ER-related gene expression in breast cancers that are1%to 10%ER-positive by immunohistochemistry显示文摘	Iwamoto T Booser D Valero V	2012	J Clin Oncol2012，30，：	1
9	Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclo-phosphamide, methotrexate, and 5- fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer 显示文摘	Ricardo H Alvarez D Booser J	2010	Cancer March2010，116，5：	1
10	Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry显示文摘	Iwamoto T Booser D Valero V		0，，07：	1
11	Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast eancer显示文摘	Esteva FJ Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
12	Phase Ⅱ study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer显示文摘	Esteva FJ Valero V Booser D		0，，：	1
13	Antracycline ant - ibiotic in cancer therapy focus on drug resistance 显示文摘	BOOSER D J HORTOBAGAYI G N	1994	Drugs1994，47，：	1
14	Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer显示文摘	IWAMOTO T BIANCHINI G BOOSER D		0，，03：	1
15	Estrogen receptor (ER) mRNA aud ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry显示文摘	Iwamoto T Booser D Valero V	2012	J Clin Oncol2012，30，7：	1
16	Phase 11 trial of weekly do- cettcxel and trastuzumab for patients with HER2-Overpressing me taslatic hreast cancer 显示文摘	Esleva F Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
17	Minimum oil requirements of ball bearings显示文摘	Booser E Wilcock D	1953	Lubrication Engineering1953，9，：	1
18	Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer 显示文摘	Esteva FJ Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
19	Phase II study of weekly docetaxel and trastuzumab for patients with HER-2- overexpressing metastatic breast cancel' 显示文摘	Esteva FJ Valero V Booser D	2002	J Clin Oncol2002，20，7：	1
20	Phase Ⅱ trial of weekly docetaxel and trastuzumab for patients with HER2-overpressing metastatic breast cancer显示文摘	Valero V Booser D	2002	J Clin Oncol2002，20，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示